The Wall Street Journal: Opioid makers cleared of liability in California lawsuitMarket Watch • 11/02/21
California Judge Rules That Teva Did Not Cause a Public Nuisance or Make False or Misleading Statements About OpioidsBusiness Wire • 11/02/21
Teva Pharmaceutical Industries Limited (TEVA) CEO Kare Schultz on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 10/27/21
Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior NotesBusiness Wire • 10/27/21
Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug CandidateBusiness Wire • 10/26/21
Teva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021Business Wire • 10/21/21
Teva to Host Conference Call to Discuss Third Quarter 2021 Financial Results at 8 a.m. ET on October 27, 2021Business Wire • 10/01/21
Teva to Present 8 Abstracts on AJOVY® (fremanezumab-vfrm) Injection and Hold Symposium on Healthcare Disparities at WCNBusiness Wire • 09/30/21
Teva Enlists Sarah Michelle Gellar to Launch “Inhaler Tales” Campaign to Raise Awareness About Inhaler Use in Asthma and COPDBusiness Wire • 09/30/21